Contract development and manufacturing organization firms Sai Life Sciences Ltd. (Hyderabad, India), Agility Life Sciences (Stapleford, UK) and Centrix Pharma Solutions (East Sussex, UK) have announced the launch of an integrated chemistry, manufacturing and controls (CMC) partnership, as per Chemweek.
This collaboration aims to provide biopharmaceutical companies with comprehensive end-to-end CMC services, enhancing the drug development process.
Sai Life Science said the partnership leverages the extensive CMC expertise of each organization: Sai Life Sciences specializes in active pharmaceutical ingredient (API) development, Agility Life Sciences focuses on formulation development, and Centrix Pharma Solutions excels in drug product development and clinical manufacturing.
By combining these strengths, the integrated CMC partnership will facilitate seamless drug substance and drug product development, enabling clients to transition efficiently from preclinical studies to first-in-human clinical trials and beyond.
The collaboration allows for integrated planning across API and drug product development, which significantly reduces duplication, risks, costs and timelines for clients, said Sai Life Science.
The partnership provides end-to-end service coverage, from synthetic route scouting and drug substance manufacturing to preformulation and clinical trial material manufacturing.
By ensuring seamless coordination between technical teams, the partnership promotes proactive sample transfer and early API evaluation within the drug product process, it added.
mrchub.com